Terms: = Breast cancer AND CHD4, Mi2-BETA, 1108, ENSG00000111642, Mi-2b, DKFZp686E06161, Q14839 AND Treatment
18 results:
1. Evidence of a synthetic lethality interaction between SETDB1 histone methyltransferase and chd4 chromatin remodeling protein in a triple negative breast cancer cell line.
Moraes-Almeida MS; Sogayar MC; Demasi MAA
Braz J Med Biol Res; 2023; 56():e12854. PubMed ID: 37970920
[TBL] [Abstract] [Full Text] [Related]
2. Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With breast cancer.
Lee JE; Kwon SH; Kwon S; Jung HI; Nam JH; Lee EK
JAMA Netw Open; 2023 Jul; 6(7):e2324852. PubMed ID: 37477917
[TBL] [Abstract] [Full Text] [Related]
3. Role of duct excision surgery in the treatment of pathological nipple discharge and detection of breast carcinoma: systematic review.
Makineli S; van Wijnbergen JWM; Vriens MR; van Diest PJ; Witkamp AJ
BJS Open; 2023 Jul; 7(4):. PubMed ID: 37459137
[TBL] [Abstract] [Full Text] [Related]
4. Intradural Extramedullary Spinal Metastases from Non-neurogenic Primary Tumors: A Systematic Review.
Palmisciano P; Chen AL; Sharma M; Bin-Alamer O; Ferini G; Umana GE; Aoun SG; Haider AS
Anticancer Res; 2022 Jul; 42(7):3251-3259. PubMed ID: 35790288
[TBL] [Abstract] [Full Text] [Related]
5. chd4 as an important mediator in regulating the malignant behaviors of colorectal cancer.
Chang CL; Huang CR; Chang SJ; Wu CC; Chen HH; Luo CW; Yip HK
Int J Biol Sci; 2021; 17(7):1660-1670. PubMed ID: 33994851
[TBL] [Abstract] [Full Text] [Related]
6. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
Mittermeier T; Farrant C; Wise MR
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
[TBL] [Abstract] [Full Text] [Related]
7. A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer.
Ho AY; Barker CA; Arnold BB; Powell SN; Hu ZI; Gucalp A; Lebron-Zapata L; Wen HY; Kallman C; D'Agnolo A; Zhang Z; Flynn J; Dunn SA; McArthur HL
Cancer; 2020 Feb; 126(4):850-860. PubMed ID: 31747077
[TBL] [Abstract] [Full Text] [Related]
8. Over-Expression of chd4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal cancers Receiving Concurrent Chemoradiotherapy.
Wang HC; Chou CL; Yang CC; Huang WL; Hsu YC; Luo CW; Chen TJ; Li CF; Pan MR
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438571
[TBL] [Abstract] [Full Text] [Related]
9. Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer.
Zaheed M; Wilcken N; Willson ML; O'Connell DL; Goodwin A
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012873. PubMed ID: 30776132
[TBL] [Abstract] [Full Text] [Related]
10. EZH2-, chd4-, and IDH-linked epigenetic perturbation and its association with survival in glioma patients.
Zhang L; Liu Y; Wang M; Wu Z; Li N; Zhang J; Yang C
J Mol Cell Biol; 2017 Dec; 9(6):477-488. PubMed ID: 29272522
[TBL] [Abstract] [Full Text] [Related]
11. The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer.
Hou MF; Luo CW; Chang TM; Hung WC; Chen TY; Tsai YL; Chai CY; Pan MR
Exp Cell Res; 2017 Oct; 359(2):458-465. PubMed ID: 28842166
[TBL] [Abstract] [Full Text] [Related]
12. 17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib.
Girgert R; Emons G; Gründker C
Oncol Rep; 2017 Feb; 37(2):1212-1218. PubMed ID: 27959426
[TBL] [Abstract] [Full Text] [Related]
13. Multiple myeloma in association with second malignancy.
Grudeva-Popova J; Nenova I; Spasova M; Yaneva M; Beleva E; Ananoshtev N
J BUON; 2013; 18(2):448-52. PubMed ID: 23818360
[TBL] [Abstract] [Full Text] [Related]
14. Brain metastases from renal cell carcinoma in the era of tyrosine kinase inhibitors.
Dudek AZ; Raza A; Chi M; Singhal M; Oberoi R; Mittapalli RK; Agarwal S; Elmquist WF
Clin Genitourin Cancer; 2013 Jun; 11(2):155-60. PubMed ID: 23265925
[TBL] [Abstract] [Full Text] [Related]
15. Is there an advantage to delivering breast boost in the lateral decubitus position?
Kannan N; Kabolizadeh P; Kim H; Houser C; Beriwal S
Radiat Oncol; 2012 Sep; 7():163. PubMed ID: 23006598
[TBL] [Abstract] [Full Text] [Related]
16. Chromodomain helicase DNA-binding protein 4 (chd4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatment.
Pan MR; Hsieh HJ; Dai H; Hung WC; Li K; Peng G; Lin SY
J Biol Chem; 2012 Feb; 287(9):6764-72. PubMed ID: 22219182
[TBL] [Abstract] [Full Text] [Related]
17. A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer.
Yardley D; Burris H; Peacock N; Raefsky E; Melnik M; Inhorn R; Shipley D; Hainsworth J
Breast Cancer Res Treat; 2010 Sep; 123(2):471-5. PubMed ID: 20658263
[TBL] [Abstract] [Full Text] [Related]
18. Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study.
Scholl SM; Lidereau R; de la Rochefordière A; Le-Nir CC; Mosseri V; Noguès C; Pouillart P; Stanley FR
Breast Cancer Res Treat; 1996; 39(3):275-83. PubMed ID: 8877007
[TBL] [Abstract] [Full Text] [Related]
